Heartseed's Chief Medical Officer, Dr. Takehiko Kaneko, will be speaking at the 3rd Heart Failure Drug Discovery & Development Summit, held from July 30 to August 1, 2024, in Boston, USA.

This summit is a key forum for heart failure research and development, bringing together over 50 teams from leading biotech and pharma companies specializing in the cardio-renal area, fibrosis, and genetic diseases. Participants will share the latest research findings and data to enhance disease understanding and advance treatments.

Dr. Kaneko will be presenting in the following two sessions:

Probing How Cell Therapy can be Utilized in Heart Failure

Date: August 1, 2024 (Day 2) at 11:15 am

Content: Delving into cell therapy using purified cardiomyocytes.  Exploring cardiac muscle regeneration through cell therapy. Investigating categories of heart failure patients this would be applicable to.

Panel Discussion: Exploring Recent Innovations with Precision Medicine

Date: August 1, 2024 (Day 2) at 11:45 am

Content: How can the capabilities of gene and cell therapy be synergistically applied in cardiovascular research. Reviewing the integration of precision medicine strategies in preclinical research. From gene therapy to cell therapy to non-coding RNA which of these therapies hold the most promise.

For more details, please visit the Heart Failure Summit.